REQUEST A DEMO
Total
USD $0.00
Search more companies

Imis Pharmaceuticals Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Imis Pharmaceuticals Pvt Ltd Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Imis Pharmaceuticals Pvt Ltd is an unlisted company, incorporated on 25/06/1981. It has its registered office in the State of Andhra Pradesh LLP, India. Company's corporate identification number (CIN) is U24239AP1981PTC003079 and registration number is 003079. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
30-17-1, Seetharampuramvijayawada -520 002
Vijayawada; Andhra Pradesh; Postal Code: 000000

Contact Details: Purchase the Imis Pharmaceuticals Pvt Ltd report to view the information.

Basic Information
Outstanding Shares:
Purchase the Imis Pharmaceuticals Pvt Ltd report to view the information.
Registered Capital:
Purchase the Imis Pharmaceuticals Pvt Ltd report to view the information.
Incorporation Date:
June 25, 1981
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Imis Pharmaceuticals Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
18.22%
Total operating revenue
18.39%
Operating profit (EBIT)
-9.4%
EBITDA
-4.98%
Net Profit (Loss) for the Period
5.77%
Total assets
15.03%
Total equity
7.35%
Operating Profit Margin (ROS)
-0.4%
Net Profit Margin
-0.12%
Return on Equity (ROE)
-0.11%
Debt to Equity Ratio
47.76%
Quick Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?